Apr11_Article
April 11, 2025

NexThera, Oculis and Bayer Report Advances in Retinal Disease Therapies

Eye drops and fewer shots: NexThera, Oculis and Bayer move the needle in retinal disease care. NexThera, Bayer and Oculis…

#2. Retinal Detachment 3
April 6, 2025

Latest Techniques for Retinal Detachment Success From APAO 2025

Presentations from retinal detachment masters at APAO/AIOC 2025 teemed with practical surgical pearls for pediatric patients, complex retinal detachments and…

popular posts
#2. Retinal Detachment 3
April 6, 2025

Latest Techniques for Retinal Detachment Success From APAO 2025

latest posts
2
October 19, 2024

AAO 2024 Subspecialty Day Update: Neovascular AMD

Sandoz’s Anti VEGF Biosimilar 02
August 13, 2024

Sandoz’s Anti-VEGF Biosimilar Secures FDA Approval for nAMD Treatment

WhatsApp Image 2024 05 29 at 10.29.19 AM
May 29, 2024

Intravitreal Bevacizumab Receives EU Approval for Wet AMD Treatment

z4889203089827_b383d19bbac9759a10fd0883c30c5733
November 17, 2023

Geeking Out on Gels and Nanos: Move over, anti-VEGF and lasers! There’s a new cool posterior segment tech in town!

COVER ART TOC
November 17, 2023

A REVOLUTION in Retinal Therapies: From anti-VEGF to TKIs and gene therapy, cutting-edge innovations are changing the landscape of medical retina

img728
October 7, 2023

Going Hybrid: Could combination therapy be the solution for patients with anti-VEGF-resistant AMD?

Discover our fascinating content at issuu

explore